Macclesfield, United Kingdom
Alderley Analytical Ltd is an independent Contract Research Organisation (CRO) based in the United Kingdom. Founded in 2014, it specializes in providing world-class bioanalytical support to drug development programs, offering a seamless solution from discovery to late-phase clinical development.
The company is known for its expertise in small molecules, large molecules, peptides, biologics, and biomarkers. By consolidating bioanalytical services under one provider, Alderley Analytical minimizes laboratory transfers and maintains comprehensive bioanalytical knowledge, facilitating rapid drug development.
The company’s GLP and GCP accreditation allows it to ensure regulatory compliance in bioanalytical methods, aligning with FDA/EMA guidelines. Alderley Analytical was last funded with £300.00K by the Northern Powerhouse Investment Fund on 07 June 2018.
Now part of Synexa Life Sciences, the company combines flexibility, responsiveness, and excellent communication, making it a reliable partner for biotech, pharma, and CRO clients in the Biotechnology, Health Care, Life Sciences, and Pharmaceutical industries.
